References
- Ashokkumar C, Talukdar A, Sun Q, et al. Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant. 2009;9(1):179–191.
- Ashokkumar C, Gupta A, Sun Q, et al. Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation. Surgery. 2009;146(2):166–173.
- Ashokkumar C, Soltys K, Mazariegos G, et al. Predicting cellular rejection with a cell-based assay: preclinical evaluation in children. Transplantation. 2017;101(1):131–140.
- Kachmar P, Nicely M, Oʼtoole L, et al. Predicting cellular rejection with a cell-based assay: preclinical evaluation in children. Transplantation. 2017;101(1):131–140.
- Soltys KA, Setoyama K, Tafaleng EN, et al. Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol. 2017; May66(5):987–1000.
- Sánchez-Fueyo A, Whitehouse G, Grageda N, et al. Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation. Am J Transplant. 2020;20(4):1125–1136. Apr
- Ashokkumar C, Shapiro R, Tan H, et al. Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation. Transplantation. 2011;92(4):433–438.
- Dekeyser M, François H, Beaudreuil S, et al. Polyomavirus-specific cellular immunity: from BK-virus-specific cellular immunity to BK-virus-associated nephropathy? Front Immunol. 2015;6:307.
- Li P, Cheng D, Wen J, et al. The immunophenotyping of different stages of BK virus allograft nephropathy. Ren Fail. 2019;41(1):855–861.
- Ashokkumar C, Bentlejewski C, Sun Q, et al. Allospecific CD154+ B cells associate with intestine allograft rejection in children. Transplantation. 2010;90(11):1226–1231.
- Sindhi R, AshokKumar C, Mazariegos G, et al. Immune monitoring in small bowel transplantation. Curr Opin Organ Transplant. 2010;15(3):349–356.